Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2012 | 12-2011 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | N/A | 15,060 |
| Other current assets | 0 | 140 |
| TOTAL | $N/A | $15,200 |
| Non-Current Assets | ||
| PPE Net | N/A | 960 |
| Other Non-Current Assets | 0 | 30 |
| TOTAL | $N/A | $990 |
| Total Assets | $N/A | $15,450 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 0 | 2,700 |
| TOTAL | $N/A | $2,700 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 0 | 1,090 |
| TOTAL | $N/A | $1,090 |
| Total Liabilities | $N/A | $3,800 |
| Shareholders' Equity | ||
| Common Shares | N/A | 5 |
| Retained earnings | N/A | -48,810 |
| Other shareholders' equity | 0 | 60,355 |
| TOTAL | $N/A | $11,650 |
| Total Liabilities And Equity | $0 | $15,450 |